Baker Avenue Asset Management’s Medpace MEDP Stock Holding History

Baker Avenue Asset Management’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$249K	Sell	471 -332	-41%	-$153K	﹤0.01%	722
2026 Q1	$386K	Buy	+803	New	+$411K	0.01%	522
2023 Q4	–	Sell	-5	Closed	-$1.21K	–	1039
2023 Q3	$1.21K	Hold	5	–	–	﹤0.01%	1237
2023 Q2	$1.2K	Hold	5	–	–	﹤0.01%	1120
2023 Q1	$940	Hold	5	–	–	﹤0.01%	1195
2022 Q4	$1.06K	Buy	+5	New	+$999	﹤0.01%	1080

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Baker Avenue Asset Management's MEDP Position: Q2 2026 in Review

Baker Avenue Asset Management reduced its Medpace (MEDP) stake by 41% in Q2 2026, selling an estimated $153K and leaving 471 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #722.

Baker Avenue Asset Management first reported a position in MEDP in Q4 2022 and has held it in 6 quarters since. The position peaked at $386K in Q1 2026. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

Baker Avenue Asset Management held 471 shares of Medpace worth $249K as of Q2 2026.
Baker Avenue Asset Management sold 332 Medpace shares in Q2 2026, an estimated $153K.
Medpace made up ﹤0.01% of Baker Avenue Asset Management's portfolio in Q2 2026, its #722 holding.
Baker Avenue Asset Management first reported a position in Medpace in Q4 2022 and has held it in 6 quarters since.
Baker Avenue Asset Management's Medpace position peaked at $386K in Q1 2026.
697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Baker Avenue Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.